Source link : https://www.newshealth.biz/health-news/johnson-johnson-pulls-plug-on-dengue-drug/
Johnson & Johnson is discontinuing its phase 2 field study on the efficacy of a candidate drug for dengue, according to a company press release. The study was designed to evaluate the efficacy of an investigational drug known as mosnodenvir for the prevention of dengue virus in adults aged 18-65 years. No safety issues were […]
Author : News Health
Publish date : 2024-10-15 10:15:17
Copyright for syndicated content belongs to the linked Source.
